CDNA - CareDx, Inc.
IEX Last Trade
21.42
-7.850 -36.648%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
35.29%
PREVIOUS CLOSE
CHG
CHG%
$29.27
-7.85
-26.82%
Fundamental analysis
8%
Profitability
0%
Dept financing
9%
Liquidity
69%
Performance
2%
Performance
5 Days
3.93%
1 Month
-11.16%
3 Months
-25.81%
6 Months
46.61%
1 Year
79.25%
2 Year
96.88%
Key data
Stock price
$21.42
DAY RANGE
$20.88 - $29.27
52 WEEK RANGE
$7.80 - $34.84
52 WEEK CHANGE
$68.66
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Reginald Seeto
Region: US
Website: caredx.com
Employees: 740
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: caredx.com
Employees: 740
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.
Recent news